These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Blastic plasmacytoid dendritic cell neoplasm and cerebral toxoplasmosis: a case report. Florescu AM, Sørensen ALT, Nielsen HV, Tolnai D, Sjö LD, Larsen KL, Al-Karagholi MA. BMC Neurol; 2022 Jun 24; 22(1):233. PubMed ID: 35751052 [Abstract] [Full Text] [Related]
5. Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow. Sadigh S, DeAngelo DJ, Garcia JS, Hasserjian RP, Hergott CB, Lane AA, Lovitch SB, Lucas F, Luskin MR, Morgan EA, Pinkus GS, Pozdnyakova O, Rodig SJ, Shanmugam V, Tsai HK, Winer ES, Zemmour D, Kim AS. Mod Pathol; 2024 Jan 24; 37(1):100352. PubMed ID: 37839675 [Abstract] [Full Text] [Related]
6. Dendritic Cell Leukemia: a Review. Tsagarakis NJ, Paterakis G. Curr Oncol Rep; 2020 May 15; 22(6):55. PubMed ID: 32415624 [Abstract] [Full Text] [Related]
7. Cytologic features of blastic plasmacytoid dendritic cell neoplasm involving liver: A case report and literature review. Ding Y, Yang J, Lindsey K. Diagn Cytopathol; 2021 Feb 15; 49(2):E80-E83. PubMed ID: 32852895 [Abstract] [Full Text] [Related]
11. Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Systematic Literature Review. Kim MJ, Nasr A, Kabir B, de Nanassy J, Tang K, Menzies-Toman D, Johnston D, El Demellawy D. J Pediatr Hematol Oncol; 2017 Oct 15; 39(7):528-537. PubMed ID: 28906324 [Abstract] [Full Text] [Related]
13. Flow Cytometry Identifies a Spectrum of Maturation in Myeloid Neoplasms Having Plasmacytoid Dendritic Cell Differentiation. Hamadeh F, Awadallah A, Meyerson HJ, Beck RC. Cytometry B Clin Cytom; 2020 Jan 15; 98(1):43-51. PubMed ID: 30614203 [Abstract] [Full Text] [Related]
14. A systematic literature review of 74 Chinese blastic plasmacytoid dendritic cell neoplasm patients. Gong C, Liu Y, Zhang M. Ther Adv Hematol; 2024 Jan 15; 15():20406207241251602. PubMed ID: 38832237 [Abstract] [Full Text] [Related]
16. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies. Laribi K, Denizon N, Besançon A, Farhi J, Lemaire P, Sandrini J, Truong C, Ghnaya H, Baugier de Materre A. Biol Blood Marrow Transplant; 2016 Aug 15; 22(8):1357-1367. PubMed ID: 27026248 [Abstract] [Full Text] [Related]
17. A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia. Song J, Li W, Bai Y, Zhou P, Niu J, Niu X, Liu Y, Liu X, Drokow EK, Sun K, Zhou H. Ann Hematol; 2024 Feb 15; 103(2):463-473. PubMed ID: 38183444 [Abstract] [Full Text] [Related]
18. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm. Johnson RC, Kim J, Natkunam Y, Sundram U, Freud AG, Gammon B, Cascio MJ. Am J Surg Pathol; 2016 Apr 15; 40(4):502-9. PubMed ID: 26796502 [Abstract] [Full Text] [Related]
20. A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm with Orbital Tumor as the Initial Symptom. Li P, Pang N, Li M, Xie J, Wang Y. Clin Lab; 2024 Apr 01; 70(4):. PubMed ID: 38623681 [Abstract] [Full Text] [Related] Page: [Next] [New Search]